Certain Killer Immunoglobulin-Like Receptor (KIR)/KIR HLA Class I Ligand Genotypes Influence Natural Killer Antitumor Activity in Myelogenous Leukemia but Not in Acute Lymphoblastic Leukemia: A Case Control Leukemia Association Study.
Autor: | Varbanova, Viktoria Plamenova1 viktoriia1982@abv.bg, Mihailova, Snejina2, Naumova, Elissaveta2, Mihaylova, Anastasiya Petrova2 |
---|---|
Zdroj: | Turkish Journal of Hematology. 2019, Vol. 36 Issue 4, p238-246. 9p. |
Databáze: | Academic Search Ultimate |
Externí odkaz: |